Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: Understanding weight loss and improvements in type 2 diabetes after bariatric surgery

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 301, Issue 1, 2011, Pages

  Scott, William R ^a   Batterham, Rachel L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Ghrelin; GLP 1; Mechanisms; Obesity; PYY

Indexed keywords

AMYLIN; CHOLECYSTOKININ; GASTROINTESTINAL HORMONE; GHRELIN; INCRETIN; LEPTIN; PEPTIDE YY [3-36]; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ANOREXIA; BARIATRIC SURGERY; CALORIC RESTRICTION; GASTRECTOMY; GLYCEMIC CONTROL; HOMEOSTASIS; HUMAN; INSULIN SENSITIVITY; LAPAROSCOPIC SLEEVE GASTRECTOMY; LAPAROSCOPIC SURGERY; LIFESTYLE MODIFICATION; MALABSORPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; ROUX Y ANASTOMOSIS; SIGNAL TRANSDUCTION; TREATMENT FAILURE; TREATMENT OUTCOME; WEIGHT REDUCTION;

BARIATRIC SURGERY; COMORBIDITY; DIABETES MELLITUS, TYPE 2; GASTRECTOMY; GASTRIC BYPASS; HUMANS; LAPAROSCOPY; OBESITY, MORBID; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 79959968543     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00038.2011     Document Type: Review

References (223)

1. Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, Basso N. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 24: 1005-1010, 2010.
2. Adami GF, Cordera R, Andraghetti G, Camerini GB, Marinari GM, Scopinaro N. Changes in serum ghrelin concentration following biliopancreatic diversion for obesity. Obes Res 12: 684-687, 2004.
3. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355: 763-778, 2006.
4. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 34: 2-11, 2008.
5. Arias E, Rostron BL, Tejada-Vera B. United States Life Tables, 2005. Natl Vital Stat Rep 58: 1-132, 2010.
6. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, Shirakami G, Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa K, Nakao K. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86: 4753-4758, 2001.
7. Arora S, Anubhuti. Role of neuropeptides in appetite regulation and obesity. Neuropeptides 40: 375-401, 2006.
8. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120: 337-345, 2001.
9. Badman MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars. Science 307: 1909-1914, 2005.
10. Baggio L, Drucker D. Biology of Incretins: GLP-1 and GIP. Gastroenterology 132: 2131-2157, 2007.
11. Balsiger BM, Poggio JL, Mai J, Kelly KA, Sarr MG. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 4: 598-605, 2000.
12. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349: 941-948, 2003.
13. Bernstine H, Tzioni-Yehoshua R, Groshar D, Beglaibter N, Shikora S, Rosenthal RJ, Rubin M. Gastric emptying is not affected by sleeve gastrectomy-scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum. Obes Surg 19: 293-298, 2009.
14. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363: 2211-2219, 2010.
15. Boey D, Sainsbury A, Herzog H. The role of peptide YY in regulating glucose homeostasis. Peptides 28: 390-395, 2007.
16. Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, Gfrerer L, Ludvik B, Zacherl J, Prager G. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 20: 535-540, 2010.
17. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg 17: 1193-1198, 2007.
18. Bose M, Machineni S, Oliván B, Teixeira J, McGinty JJ, Bawa B, Koshy N, Colarusso A, Laferrère B. Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity (Sliver Spring) 18: 1085-1091, 2010.
19. Bose M, Olivan B, Teixeira J, Pi-Sunyer FX, Laferrere B. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg 19: 217-229, 2009.
20. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 89: 2583-2589, 2004.
21. a.British Heart Foundation. Coronary Heart Disease Statistics. British Heart Foundation, 2010. [available online at http://www.bhf.org.uk/heart-health/statistics/heart-statistics-publications.aspx].
22. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, van der Lely AJ, Deghenghi R, Ghigo E. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86: 5083-5086, 2001.
23. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, Abribat T, Van Der Lely AJ, Ghigo E. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 89: 3062-3065, 2004.
24. Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA 288: 2793-2796, 2002.
25. Buchan A. Morphological and functional alterations to a sub-group of regulatory peptides in human pancreas and intestine after jejuno-ileal bypass. Int J Obes Relat Metab Disord 17: 109-113, 1993.
26. Buchwald H. Bariatric surgery: a systematic review and meta-analysis. JAMA 292: 1724-1737, 2004.
27. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122: 248-256, 2009.
28. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg 19: 1605-1611, 2009.
29. Bueter M, Löwenstein C, Ashrafian H, Hillebrand J, Bloom S, Olbers T, Lutz T, le Roux C. Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg 20: 616-622, 2010.
30. Calvani R, Miccheli A, Capuani G, Tomassini Miccheli A, Puccetti C, Delfini M, Iaconelli A, Nanni G, Mingrone G. Gut microbiomederived metabolites characterize a peculiar obese urinary metabotype. Int J Obes (Lond) 34: 1095-1098, 2010.
31. Camerini G, Adami G, Marinari GM, Gianetta E, Pretolesi F, Papadia F, Marini P, Murelli F, Carlini F, Stabilini C, Sormani MP, Scopinaro N. Thirteen years of follow-up in patients with adjustable silicone gastric banding for obesity: weight loss and constant rate of late specific complications. Obes Surg 14: 1343-1348, 2004.
32. Cani PD, Delzenne NM. Involvement of the gut microbiota in the development of low grade inflammation associated with obesity: focus on this neglected partner. Acta Gastroenterol Belg 73: 267-269, 2010.
33. Chan JL, Mun EC, Stoyneva V, Mantzoros CS, Goldfine AB. Peptide YY levels are elevated after gastric bypass surgery. Obesity (Silver Spring) 14: 194-198, 2006.
34. Chandarana K, Gelegen C, Karra E, Withers DJ, Batterham RL. Diet and gastrointestinal bypass induced weight loss: the roles of ghrelin and PYY. Diabetes 60: 810-818, 2011.
35. Chelikani PK, Shah IH, Taqi E, Sigalet DL, Koopmans HH. Comparison of the effects of Roux-en-Y gastric bypass and ileal transposition surgeries on food intake, body weight, and circulating peptide YY concentrations in rats. Obes Surg 20: 1281-1288, 2010.
36. Chen DC, Stern JS, Atkinson RL. Effects of ileal transposition on food intake, dietary preference, and weight gain in Zucker obese rats. Am J Physiol Regul Integr Comp Physiol 258: R269-R273, 1990.
37. Clements R. Hormonal changes after Roux-en-Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am Surg 70: 1-5, 2004.
38. Cone RD. Anatomy and regulation of the central melanocortin system. Nat Neurosci 8: 571-578, 2005.
39. Couce ME, Cottam D, Esplen J, Schauer P, Burguera B. Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer. Obes Surg 16: 870-878, 2006.
40. Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 89: 2608-2615, 2004.
41. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50: 1714-1719, 2001.
42. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346: 1623-1630, 2002.
43. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123: 1120-1128, 2002.
44. De Panfilis C, Cero S, Torre M, Salvatore P, Dall'Aglio E, Adorni A, Maggini C. Changes in body image disturbance in morbidly obese patients 1 year after laparoscopic adjustable gastric banding. Obes Surg 17: 792-799, 2007.
45. DeFronzo RA. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773-795, 2009.
46. DePaula AL, Macedo ALV, Schraibman V, Mota BR, Vencio S. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34. Surg Endosc 23: 1724-1732, 2008.
47. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444: 881-887, 2006.
48. DiGiorgi M, Rosen DJ, Choi JJ, Milone L, Schrope B, Olivero- Rivera L, Restuccia N, Yuen S, Fisk M, Inabnet WB, Bessler M. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis 6: 249-253, 2010.
49. Dixon AF, Dixon JB, O'Brien PE. Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab 90: 813-819, 2005.
50. Dunn JP, Cowan RL, Volkow ND, Feurer ID, Li R, Williams DB, Kessler RM, Abumrad NN. Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings. Brain Res 1350: 123-130, 2010.
51. Faraj M. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88: 1594-1602, 2003.
52. Field BCT, Chaudhri OB, Bloom SR. Bowels control brain: gut hormones and obesity. Nat Rev Endocrinol 6: 444-453, 2010.
53. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 289: 187-193, 2003.
54. Foschi D, Corsi F, Pisoni L, Vago T, Bevilacqua M, Asti E, Righi I, Trabucchi E. Plasma cholecystokinin levels after vertical banded gastroplasty: effects of an acidified meal. Obes Surg 14: 644-647, 2004.
55. Freedman DM, Ron E, Ballard-Barbash R, Doody MM, Linet MS. Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes 30: 822-829, 2006.
56. Frezza EE, Chiriva-Internati M, Wachtel MS. Analysis of the results of sleeve gastrectomy for morbid obesity and the role of ghrelin. Surg Today 38: 481-483, 2008.
57. Fruhbeck G, Diez-Caballero A, Gil MJ, Montero I, Gomez-Ambrosi J, Salvador J, Cienfuegos JA. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg 14: 606-612, 2004.
58. Fruhbeck G, Diez Caballero A, Gil MJ. Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med 350: 308-309, 2004.
59. Fruhbeck G, Rotellar F, Hernandez-Lizoain JL, Gil MJ, Gomez-Ambrosi J, Salvador J, Cienfuegos JA. Fasting plasma ghrelin con- centrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia. Obes Surg 14: 1208-1215, 2004.
60. Gan SSH, Talbot ML, Jorgensen JO. Efficacy of surgery in the management of obesity-related type 2 diabetes mellitus. ANZ J Surg 77: 958-962, 2007.
61. Garcia-Fuentes E, Garrido-Sanchez L, Garcia-Almeida JM, Garcia-Arnes J, Gallego-Perales JL, Rivas-Marin J, Morcillo S, Cardona I, Soriguer F. Different effect of laparoscopic Roux-en-Y gastric bypass and open biliopancreatic diversion of scopinaro on serum PYY and ghrelin levels. Obes Surg 18: 1424-1429, 2008.
62. Garcia-Unzueta MT, Fernandez-Santiago R, Dominguez-Diez A, Vazquez-Salvi L, Fernandez-Escalante JC, Amado JA. Fasting plasma ghrelin levels increase progressively after biliopancreatic diversion: one-year follow-up. Obes Surg 15: 187-190, 2005.
63. Geloneze B, Tambascia MA, Pilla VF, Geloneze SR, Repetto EM, Pareja JC. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg 13: 17-22, 2003.
64. Gloy VL, Lutz TA, Langhans W, Geary N, Hillebrand JJ. Basal plasma levels of insulin, leptin, ghrelin, and amylin do not signal adiposity in rats recovering from forced overweight. Endocrinology 151: 4280-4288, 2010.
65. Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB, Schneider BE, Holst JJ, Patti ME. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 92: 4678-4685, 2007.
66. Gracia JA, Martinez M, Elia M, Aguilella V, Royo P, Jimenez A, Bielsa MA, Arribas D. Obesity surgery results depending on technique performed: long-term outcome. Obes Surg 19: 432-438, 2009.
67. Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A, Nanni G, Castagneto M, Calvani M, Mingrone G. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55: 2025-2031, 2006.
68. Guijarro A, Suzuki S, Chen C, Kirchner H, Middleton FA, Nadtochiy S, Brookes PS, Niijima A, Inui A, Meguid MM. Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol 293: R1474-R1489, 2007.
69. Halmi KA, Mason E, Falk JR, Stunkard A. Appetitive behavior after gastric bypass for obesity. Int J Obes 5: 457-464, 1981.
70. Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, Christiansen JS, Jørgensen JOL. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol 56: 203-206, 2002.
71. Hanusch-Enserer U, Cauza E, Brabant G, Dunky A, Rosen H, Pacini G, Tuchler H, Prager R, Roden M. Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding. J Clin Endocrinol Metab 89: 3352-3358, 2004.
72. Hawkins SC, Osborne A, Finlay IG, Alagaratnam S, Edmond JR, Welbourn R. Paid work increases and state benefit claims decrease after bariatric surgery. Obes Surg 17: 434-437, 2007.
73. Heath V. Obesity: benefits of intensive lifestyle modification programs in the spotlight. Nat Rev Endocrinol 7: 1, 2011.
74. Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 252: 319-324, 2010.
75. Holdstock C. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 88: 3177-3183, 2003.
76. a.House of Commons Health Select Committee. Obesity. In: Third Report of Session 2003-2004. London: House of Commons Health Select Committee, 2004. available online at: http://www.publications.parliament.uk/pa/cm200304/cmselect/cmhealth/22/23.pdf.
77. Horowitz M, Collins PJ, Harding PE, Shearman DJ. Gastric emptying after gastric bypass. Int J Obes 10: 117-121, 1986.
78. Hosoda H, Kojima M, Kangawa K. Biological, physiological, and pharmacological aspects of ghrelin. J Pharm Sci 100: 398-410, 2006.
79. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140: 900-917, 2010.
80. Health Survey for England. Trend Tables. In: Online Health Survey for England 2008. [available online at http://www.ic.nhs.uk/pubs/hse08trends].
81. Hsu HC, Mountz JD. Metabolic syndrome, hormones, and maintenance of T cells during aging. Curr Opin Immunol 22: 541-548, 2010.
82. Jacobs M, Bisland W, Gomez E, Plasencia G, Mederos R, Celaya C, Fogel R. Laparoscopic sleeve gastrectomy: a retrospective review of 1- and 2-year results. Surg Endosc 24: 781-785, 2010.
83. Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, Samet JM. Body-mass index and mortality in Korean men and women. N Engl J Med 355: 779-787, 2006.
84. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy. Ann Surg 247: 401-407, 2008.
85. Karra E, Batterham RL. The role of gut hormones in the regulation of body weight and energy homeostasis. Mol Cell Endocrinol 316: 120-128, 2010.
86. Karra E, Yousseif A, Batterham RL. Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery. Trends Endocrinol Metab 21: 337-344, 2010.
87. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes 32: 1431-1437, 2008.
88. Kenler H. Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass. Am J Clin Nutr 52: 87-92, 1990.
89. Kindel TL, Yoder SM, Seeley RJ, D'Alessio DA, Tso P. Duodenaljejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. J Gastrointest Surg 13: 1762-1772, 2009.
90. Koopmans H. The effects of ileal transposition on food intake and body weight loss in VMH-obese rats. Am J Clin Nutr 35: 284-293, 1982.
91. Koopmans HS, Ferri GL, Sarson DL, Polak JM, Bloom SR. The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats. Physiol Behav 33: 601-609, 1984.
92. Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL, Wardlaw SL. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 90: 359-365, 2005.
93. Korner J, Bessler M, Inabnet W, Taveras C, Holst JJ. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 3: 597-601, 2007.
94. Korner J, Inabnet W, Conwell IM, Taveras C, Daud A, Olivero-Rivera L, Restuccia NL, Bessler M. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring) 14: 1553-1561, 2006.
95. Korner J, Inabnet W, Febres G, Conwell IM, McMahon DJ, Salas R, Taveras C, Schrope B, Bessler M. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 33: 786-795, 2009.
96. Korner J, Punyanitya M, Taveras C, McMahon DJ, Kim HJ, Inabnet W, Bessler M, Gallagher D. Sex differences in visceral adipose tissue post-bariatric surgery compared to matched non-surgical controls. Int J Body Compos Res 6: 93-99, 2008.
97. Kotidis EV, Koliakos G, Papavramidis TS, Papavramidis ST. The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: is there a hormonal contribution to the weightreducing effect of this procedure? Obes Surg 16: 554-559, 2006.
98. Kotidis EV, Koliakos GG, Baltzopoulos VG, Ioannidis KN, Yovos JG, Papavramidis ST. Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment-a prospective study. Obes Surg 16: 1425-1432, 2006.
99. Laferrere B. Effect of gastric bypass surgery on the incretins. Diabetes Metab 35: 513-517, 2009.
100. Laferrère B. The increase in GLP-1 levels and incretin effect after Roux-en-Y gastric bypass surgery (RYGBP) persists up to 1 year in patients with type 2 diabetes mellitus (T2DM) (Abstract). The Annual Obesity Society Meeting, October 20, 2007, New Orleans, LA, A7, 2007.
101. Laferrere B, Heshka S, Wang K, Khan Y, McGinty J, Teixeira J, Hart AB, Olivan B. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 30: 1709-1716, 2007.
102. Laferrere B, Swerdlow N, Bawa B, Arias S, Bose M, Olivan B, Teixeira J, McGinty J, Rother KI. Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes. J Clin Endocrinol Metab 95: 4072-4076, 2010.
103. Laferrere B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshy N, Lee H, Yapp K, Olivan B. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 93: 2479-2485, 2008.
104. Lage R. Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB J 24: 2670-2679, 2010.
105. Lakdawala MA, Bhasker A, Mulchandani D, Goel S, Jain S. Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in the Indian population: a retrospective 1 year study. Obes Surg 20: 1-6, 2010.
106. Langer FB, Bohdjalian A, Felberbauer FX, Fleischmann E, Reza Hoda MA, Ludvik B, Zacherl J, Jakesz R, Prager G. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg 16: 166-171, 2006.
107. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, Schindler K, Luger A, Ludvik B, Prager G. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 15: 1024-1029, 2005.
108. Lars S, Anders G, Sjöström CD, Kristina N, Markku P, Hans W, Calle B, Claude B, Björn C, Sven D, Peter J, Kristjan K, Jan K, Bo L, Anna-Karin L, Hans L, Ingmar N, Torsten O, Kaj S, Jarl T, Lena MSC. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 10: 653-662, 2009.
109. le Roux CW. Ghrelin does not stimulate food intake in patients with surgical procedures Involving vagotomy. J Clin Endocrinol Metab 90: 4521-4524, 2005.
110. le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, Lönroth H, Fändriks L, Ghatei MA, Bloom SR, Olbers T. Gut hormones as mediators of appetite and weight loss after Rouxen-Y gastric bypass. Ann Surg 246: 780-785, 2007.
111. Lee HM, Wang G, Englander EW, Kojima M, Greeley GH Jr. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 143: 185-190, 2002.
112. Leibel RL. Energy in, energy out, and the effects of obesity-related genes. N Engl J Med 359: 2603-2604, 2008.
113. Lenard NR, Berthoud HR. Central and peripheral regulation of food intake and physical activity: pathways and genes. Obesity (Silver Spring) 16, Suppl 3: S11-S22, 2008.
114. Leonetti F. Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endocrinol Metab 88: 4227-4231, 2003.
115. LeRoux CW, Aylwin SJB, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243: 108-114, 2006.
116. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol 26: 5-11, 2010.
117. Lin E, Gletsu N, Fugate K, McClusky D, Gu LH, Zhu JL, Ramshaw BJ, Papanicolaou DA, Ziegler TR, Smith CD. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg 139: 780-784, 2004.
118. Liou JM, Lin JT, Lee WJ, Wang HP, Lee YC, Chiu HM, Wu MS. The serial changes of ghrelin and leptin levels and their relations to weight loss after laparoscopic minigastric bypass surgery. Obes Surg 18: 84-89, 2008.
119. Liu YL, Ford HE, Druce MR, Minnion JS, Field BC, Shillito JC, Baxter J, Murphy KG, Ghatei MA, Bloom SR. Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents. Int J Obes (Lond) 34: 1715-1725, 2010.
120. Livhits M, Mercado C, Yermilov I, Parikh JA, Dutson E, Mehran A, Ko CY, Gibbons MM. Behavioral factors associated with successful weight loss after gastric bypass. Am Surg 76: 1139-1142, 2010.
121. MacLean LD, Rhode BM, Nohr CW. Long- or short-limb gastric bypass? J Gastrointest Surg 5: 525-530, 2001.
122. Maier C, Schaller G, Buranyi B, Nowotny P, Geyer G, Wolzt M, Luger A. The cholinergic system controls ghrelin release and ghrelininduced growth hormone release in humans. J Clin Endocrinol Metab 89: 4729-4733, 2004.
123. Mari A, Manco M, Guidone C, Nanni G, Castagneto M, Mingrone G, Ferrannini E. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia 49: 2136-2143, 2006.
124. McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 89: 1630-1635, 2004.
125. Melissas J, Koukouraki S, Askoxylakis J, Stathaki M, Daskalakis M, Perisinakis K, Karkavitsas N. Sleeve gastrectomy: a restrictive procedure? Obes Surg 17: 57-62, 2007.
126. Melton GB, Steele KE, Schweitzer MA, Lidor AO, Magnuson TH. Suboptimal weight loss after gastric bypass surgery: correlation of demographics, comorbidities, and insurance status with outcomes. J Gastrointest Surg 12: 250-255, 2008.
127. Mithieux G, Bady I, Gautier A, Croset M, Rajas F, Zitoun C. Induction of control genes in intestinal gluconeogenesis is sequential during fasting and maximal in diabetes. Am J Physiol Endocrinol Metab 286: E370-E375, 2004.
128. Mithieux G, Misery P, Magnan C, Pillot B, Gautier-Stein A, Bernard C, Rajas F, Zitoun C. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab 2: 321-329, 2005.
129. Moran TH. Gut peptides in the control of food intake. Int J Obes (Lond) 33, Suppl 1: S7-S10, 2009.
130. Morinigo R. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 91: 1735-1740, 2006.
131. Morinigo R, Casamitjana R, Moize V, Lacy AM, Delgado S, Gomis R, Vidal J. Short-term effects of gastric bypass surgery on circulating ghrelin levels. Obes Res 12: 1108-1116, 2004.
132. Morinigo R, Lacy AM, Casamitjana R, Delgado S, Gomis R, Vidal J. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg 16: 1594-1601, 2006.
133. Morínigo R, Vidal J, Lacy AM, Delgado S, Casamitjana R, Gomis R. Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg 247: 270-275, 2008.
134. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 443: 289-295, 2006.
135. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409: 194-198, 2001.
136. Naslund E, Backman L, Holst JJ, Theodorsson E, Hellstrom PM. Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg 8: 253-260, 1998.
137. Naslund I, Beckman KW. Gastric emptying rate after gastric bypass and gastroplasty. Scand J Gastroenterol 22: 193-201, 1987.
138. a.National Heart Lung and Blood Institute. Morbidity and Mortality Chart Book. In: Scientific Reports. Bethesda, MD: National Heart Lung and Blood Institute, 2009.
139. Neary MT, Batterham RL. Gut hormones: implications for the treatment of obesity. Pharmacol Ther 124: 44-56, 2009.
140. Neary MT, Batterham RL. Peptide YY: food for thought. Physiol Behav 97: 616-619, 2009.
141. Nijhuis J, van Dielen FM, Buurman WA, Greve JW. Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study. Obes Surg 14: 783-787, 2004.
142. O'Rahilly S. Human genetics illuminates the paths to metabolic disease. Nature 462: 307-314, 2009.
143. Ochner CN, Gibson C, Shanik M, Goel V, Geliebter A. Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes 2010.
144. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295: 1549-1555, 2006.
145. Oliván B, Teixeira J, Bose M, Bawa B, Chang T, Summe H, Lee H, Laferrère B. Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Ann Surg 249: 948-953, 2009.
146. Omana J, Nguyen S, Herron D, Kini S. Comparison of comorbidity resolution and improvement between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding. Surg Endosc 24: 2513-2517, 2010.
147. Office for National Statistics. Cancer Incidence and Mortality UK. In: Cancer Statistics Registration. [available online at http://www.statistics.gov.uk/STATBASE/Product.asp?vlnk_7720; http://www.statistics.gov.uk/StatBase/Product.asp?vlnk_14209].
148. Pacheco D, Deluis D, Romero A, Gonzalezsagrado M, Conde R, Izaola O, Aller R, Delgado A. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg 194: 221-224, 2007.
149. Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 369: 71-77, 2007.
150. Papailiou J, Albanopoulos K, Toutouzas KG, Tsigris C, Nikiteas N, Zografos G. Morbid obesity and sleeve gastrectomy: how does it work? Obes Surg 20: 1448-1455, 2010.
151. Patti ME, Houten SM, Bianco AC, Bernier R, Larsen PR, Holst JJ, Badman MK, Maratos-Flier E, Mun EC, Pihlajamaki J, Auwerx J, Goldfine AB. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) 17: 1671-1677, 2009.
152. Pattou F. Restoration of beta cell function after bariatric surgery in type 2 diabetic patients: a prospective controlled study comparing gastric banding and gastric bypass. Obes Surg 17: 1041-1042, 2007.
153. Peterli R, Wölnerhanssen B, Peters T, Devaux N, Kern B, Christoffel- Courtin C, Drewe J, von Flüe M, Beglinger C. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Ann Surg 250: 234-241, 2009.
154. Pi-Sunyer X. The medical risks of obesity. Postgrad Med 121: 21-33, 2009.
155. Pilichiewicz AN, Little TJ, Brennan IM, Meyer JH, Wishart JM, Otto B, Horowitz M, Feinle-Bisset C. Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 290: R668-R677, 2006.
156. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 52: 1098-1103, 2003.
157. Pories WJ. Ghrelin? Yes, it is spelled correctly. Ann Surg 247: 408-410, 2008.
158. Pories WJ, MacDonald KG Jr, Morgan EJ, Sinha MK, Dohm GL, Swanson MS, Barakat HA, Khazanie PG, Leggett-Frazier N, Long SD, O'Brien KF, Caro JF. Surgical treatment of obesity and its effect on diabetes: 10-year follow-up. Am J Clin Nutr 55: 582S-585S, 1992.
159. Pournaras DJ, Le Roux CW. The effect of bariatric surgery on gut hormones that alter appetite. Diabetes Metab 35: 508-512, 2009.
160. Pournaras DJ, le Roux CW. Obesity, gut hormones, and bariatric surgery. World J Surg 33: 1983-1988, 2009.
161. Prudom C, Liu J, Patrie J, Gaylinn BD, Foster-Schubert KE, Cummings DE, Thorner MO, Geysen HM. Comparison of competitive radioimmunoassays and two-site sandwich assays for the measurement and interpretation of plasma ghrelin levels. J Clin Endocrinol Metab 95: 2351-2358, 2010.
162. Raguso C, McCullough A. Leptin and the gastrointestinal tract. Curr Opin Gastroenterol 16: 160-165, 2000.
163. Rizzello M, Abbatini F, Casella G, Alessandri G, Fantini A, Leonetti F, Basso N. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg 20: 50-55, 2010.
164. Rodieux F, Giusti V, D'Alessio DA, Suter M, Tappy L. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) 16: 298-305, 2008.
165. Roth CL, Enriori PJ, Harz K, Woelfle J, Cowley MA, Reinehr T. Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss. J Clin Endocrinol Metab 90: 6386-6391, 2005.
166. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240: 236-242, 2004.
167. Rubino F, Marescaux J. Effect of duodenal??? Jejunal exclusion in a non-obese animal model of type 2 diabetes. Ann Surg 239: 1-11, 2004.
168. Sabbagh C, Verhaeghe P, Dhahri A, Brehant O, Fuks D, Badaoui R, Regimbeau JM. Two-year results on morbidity, weight loss and quality of life of sleeve gastrectomy as first procedure, sleeve gastrectomy after failure of gastric banding and gastric banding. Obes Surg 20: 679-684, 2010.
169. Sandoval DA, Obici S, Seeley RJ. Targeting the CNS to treat type 2 diabetes. Nat Rev Drug Discov 8: 386-398, 2009.
170. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238: 467-485, 2003.
171. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 232: 515-529, 2000.
172. Schindler K, Prager G, Ballaban T, Kretschmer S, Riener R, Buranyi B, Maier C, Luger A, Ludvik B. Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest 34: 549-554, 2004.
173. Schwartz GJ, Fu J, Astarita G, Li X, Gaetani S, Campolongo P, Cuomo V, Piomelli D. The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 8: 281-288, 2008.
174. Schwartz MW, Porte D Jr. Diabetes, obesity, and the brain. Science 307: 375-379, 2005.
175. Scozzari G, Farinella E, Bonnet G, Toppino M, Morino M. Laparoscopic adjustable silicone gastric banding vs laparoscopic vertical banded gastroplasty in morbidly obese patients: long-term results of a prospective randomized controlled clinical trial. Obes Surg 19: 1108-1115, 2009.
176. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (Editors). SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, [available online at http://seer.cancer.gov/csr/1975_2008/].
177. Serino M, Luche E, Chabo C, Amar J, Burcelin R. Intestinal microflora and metabolic diseases. Diabetes Metab 35: 262-272, 2009.
178. Shak JR, Roper J, Perez-Perez GI, Tseng CH, Francois F, Gamagaris Z, Patterson C, Weinshel E, Fielding GA, Ren C, Blaser MJ. The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones. Obes Surg 18: 1089-1096, 2008.
179. Shin AC, Zheng H, Pistell PJ, Berthoud HR. Roux-en-Y gastric bypass surgery changes food reward in rats. Int J Obes (Lond) 2010.
180. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351: 2683-2693, 2004.
181. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357: 741-752, 2007.
182. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, Concha H, Hassan M, Ryden M, Frisen J, Arner P. Dynamics of fat cell turnover in humans. Nature 453: 783-787, 2008.
183. Stefater MA, Perez-Tilve D, Chambers AP, Wilson-Perez HE, Sandoval DA, Berger J, Toure M, Tschop M, Woods SC, Seeley RJ. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 138: 2426-2436, 2010.
184. Stice E, Spoor S, Ng J, Zald DH. Relation of obesity to consummatory and anticipatory food reward. Physiol Behav 97: 551-560, 2009.
185. Stoeckli R, Chanda R, Langer I, Keller U. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 12: 346-350, 2004.
186. Strader A. Ileal transposition provides insight into the effectiveness of gastric bypass surgery. Physiol Behav 88: 277-282, 2006.
187. Strader AD, Vahl TP, Jandacek RJ, Woods SC, D'Alessio DA, Seeley RJ. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab 288: E447-E453, 2005.
188. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health 121: 492-496, 2007.
189. Stylopoulos N, Hoppin AG, Kaplan LM. Roux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats. Obesity (Silver Spring) 17: 1839-1847, 2009.
190. Sun Y, Asnicar M, Saha PK, Chan L, Smith RG. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 3: 379-386, 2006.
191. Sundbom M, Holdstock C, Engstrom BE, Karlsson FA. Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality? Obes Surg 17: 304-310, 2007.
192. Suter M, Calmes J, Paroz A, Giusti V. A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates. Obes Surg 16: 829-835, 2006.
193. Tadross JA, le Roux CW. The mechanisms of weight loss after bariatric surgery. Int J Obes (Lond) 33, Suppl 1: S28-S32, 2009.
194. Taqi E, Wallace LE, de Heuvel E, Chelikani PK, Zheng H, Berthoud HR, Holst JJ, Sigalet DL. The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model. J Pediatr Surg 45: 987-995, 2010.
195. Thaler JP, Cummings DE. Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150: 2518-2525, 2009.
196. Thaler JP, Schwartz MW. Inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology 151: 4109-4115, 2010.
197. Titi M, Jenkins JT, Modak P, Galloway DJ. Quality of life and alteration in comorbidity following laparoscopic adjustable gastric banding. Postgrad Med J 83: 487-491, 2007.
198. Tritos NA, Mun E, Bertkau A, Grayson R, Maratos-Flier E, Goldfine A. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res 11: 919-924, 2003.
199. Troy S, Soty M, Ribeiro L, Laval L, Migrenne S, Fioramonti X, Pillot B, Fauveau V, Aubert R, Viollet B, Foretz M, Leclerc J, Duchampt A, Zitoun C, Thorens B, Magnan C, Mithieux G, Andreelli F. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 8: 201-211, 2008.
200. Tsai AG, Wadden TA. An evaluation of major commercial weight loss programs in the United States. Ann Intern Med 142: 56-66, 2005.
201. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol 587: 4153-4158, 2009.
202. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031, 2006.
203. Valderas JP, Irribarra V, Boza C, de la Cruz R, Liberona Y, Acosta AM, Yolito M, Maiz A. Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss. J Clin Endocrinol Metab 95: 1069-1075, 2010.
204. Valverde I, Puente J, Martín-Duce A, Molina L, Lozano O, Sancho V, Malaisse W, Villanueva-Peñacarrillo M. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects. Obes Surg 15: 387-397, 2005.
205. Vazquez Roque MI, Camilleri M, Stephens DA, Jensen MD, Burton DD, Baxter KL, Zinsmeister AR. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology 131: 1717-1724, 2006.
206. Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, Gutierrez C, Simon I, Soler J, Richart C. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 12: 962-971, 2004.
207. Vidal J, Ibarzabal A, Romero F, Delgado S, Momblán D, Flores L, Lacy A. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 18: 1077-1082, 2008.
208. Vrieze A, Holleman F, Zoetendal E, de Vos W, Hoekstra J, Nieuwdorp M. The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia 53: 606-613, 2010.
209. Walley AJ, Asher JE, Froguel P. The genetic contribution to nonsyndromic human obesity. Nat Rev Genet 10: 431-442, 2009.
210. Wang PY, Caspi L, Lam CK, Chari M, Li X, Light PE, Gutierrez-Juarez R, Ang M, Schwartz GJ, Lam TK. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 452: 1012-1016, 2008.
211. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 16: 2323-2330, 2008.
212. Wang Y, Liu J. Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy. Obes Surg 19: 357-362, 2009.
213. Weiner RA, Weiner S, Pomhoff I, Jacobi C, Makarewicz W, Weigand G. Laparoscopic sleeve gastrectomy-influence of sleeve size and resected gastric volume. Obes Surg 17: 1297-1305, 2007.
214. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 71: 1057-1064, 2008.
215. Whitson B, Daniel BL, Todd AK, Michael AM, Henry B, Charles JB, Sayeed I. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. J Surg Res 141: 31-39, 2007.
216. Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg 15: 474-481, 2005.
217. Williams DL, Grill HJ, Cummings DE, Kaplan JM. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology 144: 5184-5187, 2003.
218. Wynne K, Park AJ, Small CJ, Meeran K, Ghatei MA, Frost GS, Bloom SR. Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomized controlled trial. Int J Obes (Lond) 30: 1729-1736, 2006.
219. Wynne K, Park AJ, Small CJ, Patterson M, Ellis SM, Murphy KG, Wren AM, Frost GS, Meeran K, Ghatei MA, Bloom SR. Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes 54: 2390-2395, 2005.
220. Yan LL, Daviglus ML, Liu K, Stamler J, Wang R, Pirzada A, Garside DB, Dyer AR, Van Horn L, Liao Y, Fries JF, Greenland P. Midlife body mass index and hospitalization and mortality in older age. JAMA 295: 190-198, 2006.
221. Yanovski SZ, Yanovski JA. Obesity. N Engl J Med 346: 591-602, 2002.
222. Ybarra J, Bobbioni-Harsch E, Chassot G, Huber O, Morel P, Assimacopoulos-Jeannet F, Golay A. Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss. Obes Surg 19: 327-331, 2008.
223. Zeyda M, Stulnig TM. Obesity, inflammation, and insulin resistance. Gerontology 55: 379-386, 2009.